If your ultrasound report says “polycystic ovaries” or your AMH result is high, that result alone does not mean you have PMOS. In Australian adults, PMOS, the new name for PCOS, is diagnosed only when at least two of three defined features are present after other possible causes have been excluded.
The three features are ovulatory dysfunction, clinical or biochemical androgen excess, and polycystic ovarian morphology shown by ultrasound or represented by an elevated AMH result when AMH is appropriate.
If irregular ovulation and androgen excess are both present, an adult may meet the diagnostic criteria without ultrasound or AMH. When only one of those features is present, further assessment may help determine whether a second feature exists.
Quick answers about PCOS and PMOS diagnosis
What are the PMOS diagnostic criteria in Australia?
Adults generally need at least two of three features after other causes are excluded: ovulatory dysfunction, clinical or biochemical androgen excess, and polycystic ovarian morphology defined by ultrasound or AMH where appropriate.
Do you need an ultrasound or AMH test to diagnose PMOS?
Not always. If an adult has both ovulatory dysfunction and androgen excess, those two features can satisfy the criteria. Ultrasound or AMH may help when only one of those features is present.
When should you see a GP about possible PCOS or PMOS?
Book a GP review when cycles are persistently irregular or absent, androgen-related symptoms are concerning, or a scan reports PCO or PCOM. Seek prompt assessment for rapidly worsening hair growth, voice deepening or other marked androgen changes.
Adult PCOS and PMOS diagnostic criteria: the 2 of 3 rule
The adult framework builds on the Rotterdam criteria. It does not mean choosing any two symptoms from a list. Each feature has a clinical definition, and the clinician also considers whether pregnancy, medicines or another endocrine or reproductive condition could better explain the pattern.
| Diagnostic feature | What may qualify | What it does not prove alone |
|---|---|---|
| Ovulatory dysfunction | Persistently irregular cycles, infrequent periods, absent periods or evidence that ovulation is not occurring regularly. | One unusual cycle does not diagnose PMOS. |
| Androgen excess | Clinical signs such as hirsutism, or biochemical androgen excess on suitable blood testing. | One skin or hair symptom does not automatically establish androgen excess. |
| Polycystic ovarian morphology | Current adult ultrasound criteria, or AMH used as an adult alternative where appropriate. | A scan or AMH result alone does not diagnose PMOS. |
PCOS and PMOS results decoder: what does your combination mean?
This decision aid shows why the same ultrasound or blood result can lead to different next steps. It cannot diagnose an individual person, but it can help you understand what your GP is trying to establish.
| Your current pattern | What it may mean | What usually needs clarification |
|---|---|---|
| Irregular ovulation + androgen excess | Two qualifying adult features may already be present. | Exclude other causes. Ultrasound or AMH is not automatically required. |
| Irregular ovulation + PCOM or elevated AMH | Two features may be present if the ovarian-morphology finding is valid for an adult. | Clinical assessment and exclusion of other causes still matter. |
| Androgen excess + PCOM or elevated AMH | Two features may be present even when bleeding appears regular. | Cycle and ovulation history may still need review. |
| PCOM or elevated AMH only | This does not diagnose PMOS. | Assess ovulation and androgen features rather than repeating the same morphology test. |
| Irregular periods only | This does not diagnose PMOS. | Consider androgen assessment and other causes of irregular cycles. |
| Adolescent with irregular cycles | Adult ultrasound and AMH rules should not be applied. | Persistent ovulatory dysfunction and androgen excess are both generally required. |
Important: this is a decision aid, not a diagnostic tool. A clinician needs to interpret the history, symptoms, blood results and any imaging together and exclude other possible causes.
PCO, PCOM, PCOS and PMOS: what is the difference?
PCO and PCOM mean polycystic ovarian morphology. They describe an ovarian appearance, not a complete syndrome. PCOS is the established former name for the condition now called polyendocrine metabolic ovarian syndrome, or PMOS. PCOD is an older informal term and does not create a separate diagnosis.
The international name changed in 2026 because the condition can involve ovulation, androgen hormones, metabolism, skin, mental wellbeing and long-term health. The small structures counted on ultrasound are follicles, not the same as pathological ovarian cysts. An existing PCOS diagnosis does not become invalid because the terminology changes.
Australian records and search results will continue to use both names during the transition. The PCOS to PMOS name change in Australia explains why current guidance, referrals and older reports may not use identical wording.
What counts as irregular or absent ovulation?
Cycle length is interpreted according to age and the number of years since the first period, called menarche. One late or unusual cycle does not diagnose PMOS. The repeated pattern is what matters.
During the first year after menarche, irregular cycles are common. More than 1 but less than 3 years after menarche, cycles shorter than 21 days or longer than 45 days are considered irregular. From 3 years after menarche until perimenopause, cycles shorter than 21 days, longer than 35 days or fewer than 8 cycles a year meet the irregular-cycle definition.
Any one cycle longer than 90 days more than a year after menarche needs assessment. Primary amenorrhoea also warrants review when the first period has not occurred by age 15 or more than 3 years after breast development began.
Apparently regular bleeding does not prove that every cycle ovulated. When the answer would change care, progesterone may be tested at an appropriate point after suspected ovulation. Cycle day 21 is not a universal test day because ovulation does not occur on the same day in every cycle.
The wider pattern of PCOS and PMOS symptoms in Australia can help place irregular cycles alongside hair, skin and metabolic features without turning a symptom list into a diagnosis.
How is androgen excess assessed?
Clinical androgen excess most strongly includes persistent coarse facial or body hair, called hirsutism. Severe acne and androgen-related scalp hair thinning are also assessed, although they are less specific when they occur without hirsutism.
Biochemical androgen excess is usually assessed with total testosterone and an estimate or measurement of free testosterone. Androstenedione or DHEAS may be considered when testosterone does not explain a convincing clinical pattern. Laboratory method and reference range matter because androgen measurement can be difficult at the lower concentrations expected in females.
Age, ethnicity, current medicines, cosmetic hair removal and the speed of change all affect interpretation. Rapidly developing excess hair growth, voice deepening, marked muscle change or androgen concentrations well above the laboratory range are not routine PMOS findings and need prompt assessment for another cause.
LH, FSH, oestrogen and progesterone may appear on the same pathology request, but each hormone answers a different question. Understanding how fertility hormones change across the menstrual cycle is more useful than reading one result as a PMOS score.
Which blood tests are used to diagnose PCOS or PMOS?
There is no single PCOS or PMOS blood test. Blood investigations are selected to assess androgen activity, exclude realistic alternative causes and check associated health risks.
| Clinical question | Possible test | Important limit |
|---|---|---|
| Is biochemical androgen excess present? | Total and free testosterone, with other androgens in selected cases | Interpretation depends on the assay, reference range, symptoms and medicine history. |
| Could another condition explain irregular periods? | Pregnancy test, TSH, prolactin, 17-hydroxyprogesterone, FSH or oestradiol as indicated | Not everyone needs every exclusion test. |
| Did ovulation probably occur? | Appropriately timed progesterone | It can support recent ovulation but does not provide an exact ovulation time or diagnose PMOS. |
| Is glucose follow-up needed? | 75 g oral glucose tolerance test, or fasting glucose and HbA1c when an OGTT cannot be done | These assess metabolic health and do not add to the 2 of 3 diagnostic count. |
| What other cardiometabolic checks are relevant? | Lipid profile and blood pressure | Normal results do not exclude PMOS. |
The LH-to-FSH ratio is not a diagnostic criterion. Routine insulin measurements are also not recommended as a stand-alone way to diagnose PMOS or insulin resistance. The role and limits of glucose testing are explained further in PMOS and insulin resistance in Australia.
When is pelvic ultrasound needed, and what are the PCOS ultrasound criteria?
Pelvic ultrasound can help when an adult has only one of the first two diagnostic features, when another pelvic condition needs consideration or when the uterine lining requires assessment. It may be transvaginal or transabdominal depending on age, consent, clinical need and the view that can be obtained.
With suitable modern transvaginal equipment, the preferred adult threshold for polycystic ovarian morphology is 20 or more follicles measuring 2 to 9 mm in at least one ovary. When a reliable complete follicle count is not possible, ovarian volume of at least 10 mL or follicle number per section of at least 10 may be used according to the imaging protocol.
The report should also account for scan route, equipment, cycle stage, dominant follicles, a corpus luteum and other ovarian findings. A normal ultrasound does not exclude PMOS when ovulatory dysfunction and androgen excess are present.
Can AMH replace ultrasound for PMOS diagnosis?
In adults, anti-Müllerian hormone, or AMH, may be used instead of ultrasound to define the ovarian-morphology feature when that information is needed. It does not replace the clinical assessment and cannot diagnose PMOS by itself.
AMH and ultrasound should not routinely be ordered together merely to measure the same feature. AMH varies with age, laboratory method, hormonal contraception and individual factors, so there is no universal number that diagnoses PMOS across every Australian laboratory.
AMH is not recommended for adolescent diagnosis and it is not an egg-quality test. The clinical boundaries of AMH testing for PCOS and PMOS are important when a high result has created more questions than answers.
How is PCOS or PMOS diagnosed in teenagers?
Adolescent diagnosis is intentionally stricter because irregular cycles, acne and multifollicular ovaries can overlap with normal puberty. Both persistent ovulatory dysfunction and clinical or biochemical androgen excess are generally required after other causes are excluded.
Ultrasound and AMH are not recommended for diagnosis during adolescence. When symptoms are important but the full criteria are not yet met, the clinician may document increased risk and arrange reassessment rather than applying an uncertain diagnosis.
This approach should not minimise distress. Long gaps between periods, significant hair or skin changes and symptoms affecting wellbeing still deserve appropriate care while the diagnosis remains under review.
How do the pill, pregnancy and breastfeeding affect testing?
The combined oral contraceptive pill can make withdrawal bleeds appear regular and can alter androgen concentrations, sex hormone-binding globulin and ovarian measures. A cycle pattern recorded before the pill may therefore be more informative than the current bleeding schedule.
If biochemical androgen testing is essential, a clinician may discuss stopping the combined pill for at least 3 months while reliable alternative contraception is used. Do not stop contraception without a plan because the decision depends on pregnancy intentions, symptom control and whether the result will change care.
Pregnancy should be considered whenever it is possible. Recent pregnancy and breastfeeding can also alter cycles and reproductive hormone patterns, so assessment is individualised rather than based on one universal postpartum testing date.
Which conditions can look like PCOS or PMOS?
PMOS is diagnosed after considering other explanations for irregular periods or androgen-related signs. Pregnancy, thyroid disease, raised prolactin, non-classic congenital adrenal hyperplasia, functional hypothalamic amenorrhoea and primary ovarian insufficiency can produce part of the same pattern.
The history may also point toward medicine-related changes, Cushing syndrome or another uncommon endocrine condition. Rapid symptom progression, virilisation or markedly elevated androgen results may require prompt investigation for an androgen-secreting ovarian or adrenal condition.
The exact exclusion panel depends on the person. A targeted assessment is more useful than ordering every possible test without a clinical question.
Can you test for PCOS or PMOS at home?
No home test can diagnose PMOS. Cycle dates, bleeding patterns, cervical mucus, urinary LH results and basal body temperature can help describe what is happening, but they cannot establish the syndrome or explain why ovulation is irregular.
If urinary LH tracking would make cycle timing easier to record, ovulation tests can show an LH rise. A positive result does not confirm egg release, and repeated or unclear patterns can occur when cycles are irregular.
Using a wider testing window and more than one cycle sign may provide better context when tracking ovulation with PMOS. Do not delay a GP appointment while waiting to create a perfect chart, and stop tracking if it is increasing anxiety without improving a decision.
What should you bring to a PCOS or PMOS GP appointment?
A useful appointment starts with the pattern, not a perfect folder of paperwork. Six to 12 months of cycle dates can show whether irregularity is persistent. Record when hair, acne or scalp changes began, whether they are stable or progressing, and whether the cycle pattern existed before hormonal contraception.
PMOS diagnosis appointment card
Bring: cycle dates, current and recent medicines, contraception history, previous blood tests or scans, family history and pregnancy goals.
Ask: which diagnostic features are present, which alternative causes have been considered, and whether ultrasound or AMH would change the conclusion.
Record: which tests are being ordered, what each test is intended to answer, possible fees and when the results will be reviewed together.
A GP can begin and often coordinate the assessment. Costs vary by clinic, pathology provider, imaging service, Medicare eligibility and whether each provider bulk bills. Ask about possible fees before testing because a referral or Medicare rebate does not guarantee that every service will be free.
What happens after diagnosis, and when is referral useful?
Diagnosis is the starting point for an individual care plan. Priorities may include cycle management, protection of the uterine lining, androgen-related skin or hair symptoms, contraception, glucose and cardiovascular risk, sleep, mental wellbeing and pregnancy planning.
When pregnancy is the main goal, PMOS fertility and pregnancy care in Australia can help separate ovulation questions from the broader preconception assessment.
Referral may be useful when the criteria remain uncertain, symptoms progress rapidly, periods are absent for long intervals, bleeding is concerning, metabolic risk is complex or fertility treatment may be needed. An endocrinologist may help with difficult hormone or metabolic patterns, a gynaecologist with bleeding or pelvic concerns, and a fertility specialist when pregnancy is the main unresolved goal.
Frequently Asked Questions about PCOS and PMOS Diagnosis in Australia
Can you have PMOS with a normal ultrasound?
Yes. An adult can meet the criteria through ovulatory dysfunction and androgen excess after other causes are excluded. A normal ultrasound does not rule out PMOS when those two features are present.
Can regular periods rule out PMOS?
No. Apparently regular bleeding does not prove that ovulation occurs in every cycle. If other features are present, a clinician may review the pattern and consider appropriately timed progesterone testing when the answer would change care.
Does the LH-to-FSH ratio diagnose PMOS?
No. LH and FSH may be measured while investigating irregular or absent periods, but their ratio is not one of the PMOS diagnostic criteria and cannot confirm or exclude the condition by itself.
Is PCOD different from PCOS or PMOS?
PCOD is an older informal term still seen on some websites and records. Australian clinical guidance uses PCOS and now PMOS for the syndrome. PCOD does not create a separate set of diagnostic criteria.
Can a GP diagnose PCOS or PMOS, or is a specialist needed?
A GP can begin and often coordinate the diagnostic assessment. Referral may help when the criteria remain uncertain, symptoms progress rapidly, bleeding is concerning, metabolic risk is complex or fertility treatment may be needed.
How much does PMOS testing cost in Australia?
Costs vary by GP, pathology and imaging provider, Medicare eligibility and whether each service bulk bills. Ask about fees before testing because a referral or Medicare rebate does not guarantee there will be no out-of-pocket cost.
Next Steps in Australia
Book a GP appointment when periods are persistently irregular or absent, androgen-related symptoms are concerning, or an ultrasound report mentions PCO or PCOM. Bring cycle dates, medicine and contraception details, previous results and your pregnancy goals.
Ask which diagnostic features are present, which alternative causes have been considered and whether ultrasound or AMH would change the conclusion. Arrange a follow-up appointment so the history, examination, pathology and imaging are interpreted as one clinical picture.
Seek prompt medical assessment for rapidly worsening hair growth, voice deepening, marked muscle change, androgen results well above the laboratory range, prolonged absence of periods, heavy or unusual bleeding, or another symptom that is significantly different from your usual pattern.
Last reviewed: 5 September 2026
Next scheduled review: September 2027
References
Fertility2Family articles are researched using Australian Government health guidance, professional clinical recommendations and peer-reviewed medical literature. These sources were used to research and evidence-check the medical statements in this article.
Monash Centre for Health Research and Implementation. PCOS Guideline/ PMOS Guideline
Current Australian-led guideline hub linking updated PMOS recommendations, diagnostic criteria, algorithms and clinical resources for adult and adolescent assessment in Australia.
The Journal of Clinical Endocrinology & Metabolism. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
Primary peer-reviewed recommendations covering adult criteria, cycle thresholds, androgen assessment, ultrasound, AMH, adolescent diagnosis, metabolic screening and exclusion of alternative causes.
The Medical Journal of Australia. Summary of the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective
Australian clinical summary explaining the diagnostic pathway, AMH as an adult ultrasound alternative, stricter adolescent criteria and assessment of cardiometabolic health.
Healthdirect Australia. Polycystic ovarian syndrome (PCOS)
Australian consumer guidance on PCOS and PMOS symptoms, diagnosis, blood tests, ultrasound, health risks and the role of GP-led assessment.
Jean Hailes for Women’s Health. Polycystic Ovary Syndrome (PCOS)
Australian women’s health guidance covering diagnostic features, blood testing, ultrasound, AMH, adolescent caution and questions to discuss with a health professional.
Better Health Channel, Victorian Department of Health. Polyendocrine metabolic ovarian syndrome (PMOS)
Victorian public-health information explaining the PMOS name, whole-body features, diagnostic assessment, long-term health considerations and available Australian care pathways for patients.
The Lancet. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process
Peer-reviewed 2026 consensus describing the global process that changed the name from PCOS to PMOS and the rationale for the transition.
Queensland Health. Polycystic Ovarian Syndrome (PCOS)
Australian clinical referral criteria summarising diagnostic features, relevant investigations, exclusion tests and circumstances that warrant specialist or urgent gynaecological assessment.
Services Australia. Bulk billing
Australian Medicare guidance explaining what bulk billing means, provider choice and why patients should confirm possible fees before appointments, pathology or imaging.